Study of a new injection in healthy adults in China
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new medicine for healthy people to see how safe it is and how the body handles it. It is a first step in developing a treatment for conditions like allergies or asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- Your body mass index (BMI) is between 19 and 26
- You are in generally good health
- You are not able to have children, or if you are, you use effective birth control
- You have no history of severe allergies or allergic reactions to the study medicine
- You are not smoking more than 5 cigarettes per day and can stop smoking during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new ointment called CU-10101. It will first be tested in healthy volunteers to check safety, and then in people with atopic dermatitis (eczema) to see how well it works for mild to moderate symptoms.
This study tests a new injected medication called XKH001 for people with moderate-to-severe atopic dermatitis (a type of eczema) that hasn't improved with standard creams. The goal is to see if it can reduce the severity of eczema and itching.
This trial is testing a new drug called HXN5003 in healthy volunteers to find the safest dose and see how the body handles it. It's an early-stage study, so the main goal is safety, not treating a disease.
This study tests a new investigational drug, called HRS-8797, in healthy people to see how safe it is and how the body processes it. It's an early-phase trial, so you may not directly benefit, but your participation can help find new treatments for future patients.
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
This study tests a new injectable medication called MG-K10 for people with moderate to severe atopic dermatitis (eczema). The goal is to see if it reduces itching and clears skin better than a placebo. If you've tried topical treatments without enough relief, this might be an option.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.